BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis
Abstract In the present study, we investigated the involvement of the chaperone protein BiP (also known as GRP78 or Hspa5),…
Abstract In the present study, we investigated the involvement of the chaperone protein BiP (also known as GRP78 or Hspa5),…
Abstract The phytocannabinoid-based medicine Sativex® is currently marketed for the treatment of spasticity and pain in multiple sclerosis patients and…
Abstract Targeting of the CB2 receptor results in neuroprotection in the SOD1G93A mutant mouse model of amyotrophic lateral sclerosis (ALS).…